DRUG
Bright Minds Biosciences
DRUG
DRUG
6 hedge funds and large institutions have $309K invested in Bright Minds Biosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$173K | |
| 2 | +$35.6K | |
| 3 | +$34.9K | |
| 4 |
APC
Aspire Private Capital
Cornelius,
North Carolina
|
+$267 |
Top Sellers
| 1 | -$9.53K | |
| 2 | -$8.06K | |
| 3 | -$6.29K | |
| 4 |
Renaissance Technologies
New York
|
-$6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.2K |